Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes

References

• Akaike H (1974). A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723.
   Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799.
   PubMed Web of Science ®Google Scholar
• Aylward EH, Brettschneider PD, McArthur JC, Harris GJ, Schlaepfer TE, Henderer JD, Barta PE, Tien AY, Pearlson GD (1995). Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152:987–994.
   PubMed Web of Science ®Google Scholar
• Antuono PG, Jones JL, Wang Y, Li SJ (2001). Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T. Neurology 56:737–742.
   PubMedGoogle Scholar
• Alemán-Gómez Y, Melie-García L, Valdés-Hernandez P (2006). IBASPM: toolbox for automatic parcellation of brain structures. Paper presented at Organization for Human Brain Mapping meeting; Florence, Italy; June 11–15, 2006.
   Google Scholar
• Brew BJ (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1): S75–S78.
   Google Scholar
• Burnham KP, Anderson DR (2002). Model selection and multimodel inference: a practical-theoretic approach, 2nd ed. New York: Springer.
   Google Scholar
• Broom KA, Anthony DC, Lowe JP, Griffin JL, Scott H, Blamire AM, Styles P, Perry VH, Sibson NR (2007). MRI and MRS alterations in the preclinical phase of murine prion disease: association with neuropathological and behavioural changes. Neurobiol Dis 26:07–717.
   Google Scholar
• Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. (2009). Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol 4:163–174.
   PubMed Web of Science ®Google Scholar
• Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F (2006). Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 7:86–96.
   PubMed Web of Science ®Google Scholar
• Brew BJ, Rosenblum M, Cronin K, Price RW (1995). AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 38:563–570.
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E (1999). Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 52:100–108.
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Tornatore C, Aronow H, Melchor R, Walot I, Singer E, Cornford M (1997). Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 48:836–845.
   Google Scholar
• Chang L, Ernst T, Witt MD, Ames N, Gaiefsky M (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. NeuroImage 17:1638–1648.
   PubMed Web of Science ®Google Scholar
• Chang L, Ernst T, Witt MD, Ames N, Walot I, Jovicich J, DeSilva M, Trivedi N, Speck O, Miller EN (2003). Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART. Antivir Ther 8:17–26.
   PubMed Web of Science ®Google Scholar
• Cohen RA, Harezlak J, Schifitto G, (2010). Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. J NeuroVirol 16:25–32.
   PubMed Web of Science ®Google Scholar
• Chang L, Lee PL, Yiannoutsos CT, Ernst T, Marra CM, Richards T, Kolson D, Schifitto G, Jarvik JG, Miller EN, Lenkinski R, Gonzalez G, Navia BA (2004). A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. NeuroImage 23:1336–1347.
   PubMed Web of Science ®Google Scholar
• Gropman AL, Batshaw ML (2004). Cognitive outcome in urea cycle disorders. Mol Genet Metab 81(Suppl 1): S58–S62.
   Google Scholar
• Gongvatana A, Schweinsburg BC, Taylor MJ, Theilmann RJ, Letendre SL, Alhassoon OM, Jacobus J, Woods SP, Jernigan TL, Ellis RJ, Frank LR, Grant I (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J NeuroVirol 15:187–195.
   PubMed Web of Science ®Google Scholar
• Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA (1994). The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol 51:1129–1135.
   PubMedGoogle Scholar
• Jernigan TL, Archibald S, Hesselink JR, Atkinson JH, Velin RA, McCutchan JA, Chandler J, Grant I (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Arch Neurol 50:250–255.
   PubMed Web of Science ®Google Scholar
• Jones RS, Waldman AD (2004). 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurol Res 26:488–495.
   PubMed Web of Science ®Google Scholar
• Kreis R, Arcinue E, Ernst T, Shonk TK, Flores R, Ross BD (1996). Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J Clin Invest 97:1142–1154.
   PubMedGoogle Scholar
• Lentz MR, Kim WK, Lee V, Bazner S, Halpern EF, Venna N, Williams K, Rosenberg ES, Gonzalez RG (2009). Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 72:1465–1472.
   Google Scholar
• Long LL, Li XR, Huang ZK, Jiang YM, Fu SX, Zheng W (2009). Relationship between changes in brain MRI and (1)H-MRS, severity of chronic liver damage, and recovery after liver transplantation. Exp Biol Med (Maywood) 234:1075–1085.
   PubMed Web of Science ®Google Scholar
• Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, Gonzalez RG, Navia BA (2003). A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 17:625–633.
   PubMed Web of Science ®Google Scholar
• McArthur JC (2004). HIV dementia: an evolving disease. J Neuroimmunol 157:3–10.
   PubMed Web of Science ®Google Scholar
• Provencher SW (2001). Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 14:260–264.
   PubMed Web of Science ®Google Scholar
• Paul RH, Ernst T, Brickman AM, Yiannoutsos CT, Tate DF, Cohen RA, Navia BA (2008). Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. J Int Neuropsychol Soc 14:725–733.
   Google Scholar
• Patel SH, Inglese M, Glosser G, Kolson DL, Grossman RI, Gonen O (2003). Whole-brain N-acetylaspartate level and cognitive performance in HIV infection. AJNR Am J Neuroradiol 24:1587–1591.
   PubMed Web of Science ®Google Scholar
• Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, Lenkinski RE, Cohen RA, Navia BA (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. J Neuropsychiatry Clin Neurosci 19:283–292.
   PubMed Web of Science ®Google Scholar
• Ross B, Bluml S (2001). Magnetic resonance spectroscopy of the human brain. Anat Rec 265:54–84.
   PubMedGoogle Scholar
• Ratai EM, Pilkenton SJ, Greco JB, Lentz MR, Bombardier JP, Turk KW, He J, Joo CG, Lee V, Westmoreland S, Halpern E, Lackner AA, Gonzalez RG (2009). In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci 10:63.
   Google Scholar
• Sijens PE, Alkefaji H, Lunsing RJ, van Spronsen FJ, Meiners LC, Oudkerk M, Verkade HJ (2008). Quantitative multivoxel 1H MR spectroscopy of the brain in children with acute liver failure. Eur Radiol 18:2601–2609.
   Google Scholar
• Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 8:136–142.
   PubMed Web of Science ®Google Scholar
• Sacktor N, Skolasky RL, Ernst T, Mao X, Selnes O, Pomper MG, Chang L, Zhong K, Shungu DC, Marder K, Shibata D, Schifitto G, Bobo L, Barker PB (2005). A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging 21:325–333.
   PubMed Web of Science ®Google Scholar
• Schweinsburg BC, Taylor MJ, Alhassoon OM, Gonzalez R, Brown GG, Ellis RJ, Letendre S, Videen JS, McCutchan JA, Patterson TL, Grant I (2005). Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J NeuroVirol 11:356–364.
   PubMed Web of Science ®Google Scholar
• Schifitto G, Yiannoutsos CT, Ernst T, Navia BA, Nath A, Sacktor N, Anderson C, Marra CM, Clifford DB (2009a). Selegiline and oxidative stress in HIV-associated cognitive impairment. Neurology 73:1975–1981.
   Web of Science ®Google Scholar
• Schifitto G, Zhong J, Gill D, Peterson DR, Gaugh MD, Zhu T, Tivarus M, Cruttenden K, Maggirwar SB, Gendelman HE, Dewhurst S, Gelbard HA (2009b). Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment. J NeuroVirol 15:176–186.
   PubMed Web of Science ®Google Scholar
• Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, Becker JT (2005). Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A 102:15647–15652.
   PubMed Web of Science ®Google Scholar
• Tkac I, Dubinsky JM, Keene CD, Gruetter R, Low WC (2007). Neurochemical changes in Huntington R6/2 mouse striatum detected by in vivo 1H NMR spectroscopy. J Neurochem 100:1397–1406.
   Google Scholar
• Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002). Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. NeuroImage 15:273–289.
   PubMed Web of Science ®Google Scholar
• Tate D, Harezlak J, Price J, Dewey J, Yiannoutsos C, Campbell T, Daar E, McMahon D, Schifitto G, Zhong J, Taylor M Singer E, Alger J, Brown M, Cohen R, Navia B (2010). Progressive brain atrophy in chronic HIV infection: longitudinal analysis of the HIVNC Cohort Study. Human Brain Mapping. Barcelona, Spain; June 6–10, 2010.
   Google Scholar
• Tarasow E, Wiercinska-Drapalo A, Kubas B, Dzienis W, Orzechowska-Bobkiewicz A, Prokopowicz D, Walecki J (2003). Cerebral MR spectroscopy in neurologically asymptomatic HIV-infected patients. Acta Radiol 44:206–212.
   Google Scholar
• Valcour V, Sacktor N (2002). HIV-associated dementia and aging. J Ment Health Aging 8:295–306.
   Google Scholar
• Valcour V, Shikuma C, Waters M, Sacktor N (2004). Cognitive impairment in older HIV-1 seropositive individuals: prevalence and potential mechanisms. AIDS 18(Suppl 1): S79–S86.
   Google Scholar
• Yiannoutsos CT, Ernst T, Chang L, Lee PL, Richards T, Marra CM, Meyerhoff DJ, Jarvik JG, Kolson D, Schifitto G, Ellis RJ, Swindells S, Simpson DM, Miller EN, Gonzalez RG, Navia BA (2004). Regional patterns of brain metabolites in AIDS dementia complex. NeuroImage 23:928–935.
   PubMed Web of Science ®Google Scholar